1374771-97-7

Basic information

• Product Name: (3R,55,6E)-7-[4-(4-fluorophenyl)-2-(N-(methyl)methanesulfonamide)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid lysine salt
• Synonyms: (3R,55,6E)-7-[4-(4-fluorophenyl)-2-(N-(methyl)methanesulfonamide)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid lysine salt
• CAS NO: 1374771-97-7
• Molecular Weight: 627.735
• Mol File: 1374771-97-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (3R,55,6E)-7-[4-(4-fluorophenyl)-2-(N-(methyl)methanesulfonamide)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid lysine salt(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,55,6E)-7-[4-(4-fluorophenyl)-2-(N-(methyl)methanesulfonamide)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid lysine salt(1374771-97-7)
• EPA Substance Registry System: (3R,55,6E)-7-[4-(4-fluorophenyl)-2-(N-(methyl)methanesulfonamide)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid lysine salt(1374771-97-7)

Safety Data

• Hazardous Substances Data: 1374771-97-7(Hazardous Substances Data)

Upstream product

• 21653-99-6 L-lysine 
• 287714-41-4 rosuvastatin 
• 289042-12-2 2-[(4R,6S)-6-[(E)-2-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(isopropyl)pyrimidin-5-yl]vinyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid tert butyl ester 
• 56-87-1 L-lysine 
• 657-27-2 L-Lysine hydrochloride 

Relevant articles and documents

A he rosuvastain sandbank amino acid salt and its preparation method and application

The invention relates to a rosuvastatin amino acid salt as well as a preparation method of the rosuvastatin amino acid salt. Such a compound, namely, amino acid salt, is prepared through the reaction between rosuvastatin acid and basic amino acid. The preparation method comprises the following steps of: (1) weighing rosuvastatin acid, and dissolving into C1-C6 alcohol solvents, water or a halohydrocarbon solution to obtain a solution A; (2) weighing basic amino acid, and dissolving into C1-C6 alcohol solvents or water to obtain a solution B; (3) adding the solution B to the solution A, stirring and remaining overnight, cooling the reaction liquid to reach room temperature, and then vaporizing and eliminating the solvents; (4) adding methanol, separating and filtering to remove excessive basic amino acid; and (5) concentrating, refluxing, cooling, filtering and drying to obtain the amino acid salt of the rosuvastatin. The rosuvastatin amino acid salt prepared by the preparation method not only has the effect of treating high cholesterol blood lipid and combined hyperlipidemia, and also gains the function of amino acid, thus the salt effectively fills in gaps due to the known side effects of hurt of calcium salt, sylvite and sodium salt and the like to the liver.

PROCESS FOR THE PREPARATION OF ROSUVASTATIN CALCIUM VIA NOVEL AMINE INTERMEDIATE

The present invention, relates to novel amine salts of rosuvastatin and its process for the preparation. Moreover, the present invention also relates to improved process for the preparation of rosuvastatin calcium, employing novel amine salts as an intermediate.